Blend Labs (BLND) Projected to Post Quarterly Earnings on Thursday

Blend Labs (NYSE:BLND) is projected to announce its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect the company to announce earnings of $0.01 per share for the quarter. Investors are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, February 27, 2026 at 4:00 PM ET.

Blend Labs Price Performance

Shares of NYSE BLND opened at $1.75 on Thursday. Blend Labs has a one year low of $1.64 and a one year high of $4.49. The business’s 50-day moving average price is $2.72 and its two-hundred day moving average price is $3.17. The company has a market capitalization of $453.26 million, a P/E ratio of -17.45 and a beta of 1.23.

Insider Buying and Selling at Blend Labs

In related news, insider Brian Kneafsey sold 25,000 shares of the firm’s stock in a transaction on Thursday, January 15th. The shares were sold at an average price of $3.06, for a total value of $76,500.00. Following the transaction, the insider directly owned 649,824 shares in the company, valued at approximately $1,988,461.44. This trade represents a 3.70% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 35.52% of the company’s stock.

Institutional Investors Weigh In On Blend Labs

A number of hedge funds have recently bought and sold shares of BLND. Caitong International Asset Management Co. Ltd bought a new stake in shares of Blend Labs during the third quarter valued at approximately $32,000. Captrust Financial Advisors acquired a new stake in Blend Labs during the second quarter worth $35,000. Jump Financial LLC bought a new stake in Blend Labs in the 2nd quarter valued at $38,000. Wexford Capital LP bought a new stake in Blend Labs in the 3rd quarter valued at $45,000. Finally, Cibc World Markets Corp acquired a new position in shares of Blend Labs in the 4th quarter valued at $40,000. 52.56% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages recently commented on BLND. Canaccord Genuity Group reissued a “buy” rating and issued a $5.25 price target on shares of Blend Labs in a research note on Tuesday, October 28th. Weiss Ratings reissued a “sell (d-)” rating on shares of Blend Labs in a research report on Wednesday, January 21st. UBS Group dropped their price target on shares of Blend Labs from $3.50 to $3.00 and set a “neutral” rating on the stock in a research note on Monday, November 10th. Finally, Wall Street Zen raised shares of Blend Labs from a “sell” rating to a “hold” rating in a research note on Sunday, November 16th. Four investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $4.80.

Blend Labs Company Profile

Blend Labs, Inc operates as a financial technology company that offers a digital consumer banking platform designed to simplify and automate the lending and account opening processes for banks and credit unions. Its cloud-native software enables financial institutions to deliver a more seamless customer experience by consolidating multiple steps—such as application intake, identity verification, document collection and underwriting—into a unified digital workflow. Blend’s platform is built to integrate with existing core banking systems and third-party data providers, allowing clients to accelerate loan origination and deposit account opening while maintaining compliance and security standards.

The company’s product suite includes solutions for mortgage origination, home equity lending, consumer personal lending and deposit account opening.